• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调整聚合物和多孔硅复合纳米粒子的组成以实现抗 microRNA 肽核酸的早期内体逃逸。

Tuning Composition of Polymer and Porous Silicon Composite Nanoparticles for Early Endosome Escape of Anti-microRNA Peptide Nucleic Acids.

机构信息

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.

Vanderbilt Institute of Nanoscale Science and Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.

出版信息

ACS Appl Mater Interfaces. 2020 Sep 2;12(35):39602-39611. doi: 10.1021/acsami.0c05827. Epub 2020 Aug 21.

DOI:10.1021/acsami.0c05827
PMID:32805967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8356247/
Abstract

Porous silicon nanoparticles (PSNPs) offer tunable pore structure and easily modified surface chemistry, enabling high loading capacity for drugs with diverse chemicophysical properties. While PSNPs are also cytocompatible and degradable, PSNP integration into composite structures can be a useful approach to enhance carrier colloidal stability, drug-cargo loading stability, and endosome escape. Here, we explored PSNP polymer composites formed by coating of oxidized PSNPs with a series of poly[ethylene glycol--(dimethylaminoethyl methacrylate--butyl methacrylate)] (PEG-DB) diblock copolymers with varied molar ratios of dimethylaminoethyl methacrylate (D) and butyl methacrylate (B) in the random copolymer block. We screened and developed PSNP composites specifically toward intracellular delivery of microRNA inhibitory peptide nucleic acids (PNA). While a copolymer with 50 mol % B (50B) is optimal for early endosome escape in free polymer form, its pH switch was suppressed when it was formed into 50B polymer-coated PSNP composites (50BCs). We demonstrate that a lower mol % B (30BC) is the ideal PEG-DB composition for PSNP/PEG-DB nanocomposites based on having both the highest endosome disruption potential and miR-122 inhibitory activity. At a 1 mM PNA dose, 30BCs facilitated more potent inhibition of miR-122 in comparison to 40BC ( = 0.0095), 50BC ( < 0.0001), or an anti-miR-122 oligonucleotide delivered with the commercial transfection reagent Fugene 6. Using a live cell galectin 8-based endosome disruption reporter, 30BCs had greater endosomal escape than 40BCs and 50BCs within 2 h after treatment, suggesting that rapid endosome escape correlates with higher intracellular bioactivity. This study provides new insight on the polymer structure-dependent effects on stability, endosome escape, and cargo intracellular bioavailability for endosomolytic polymer-coated PSNPs.

摘要

多孔硅纳米粒子 (PSNPs) 具有可调的孔结构和易于修饰的表面化学性质,能够实现对具有不同理化性质的药物的高载药量。虽然 PSNPs 也是细胞相容的和可降解的,但将 PSNP 整合到复合结构中是一种有用的方法,可以提高载体胶体稳定性、药物货物载药量稳定性和内涵体逃逸。在这里,我们探索了由一系列聚[乙二醇-(二甲氨基乙基甲基丙烯酸酯-丁基甲基丙烯酸酯)](PEG-DB)嵌段共聚物涂覆氧化 PSNPs 形成的 PSNP 聚合物复合材料,其中聚乙二醇-(二甲氨基乙基甲基丙烯酸酯-丁基甲基丙烯酸酯)](PEG-DB)嵌段共聚物中的二甲氨基乙基甲基丙烯酸酯(D)和丁基甲基丙烯酸酯(B)的摩尔比不同。我们筛选并开发了专门用于细胞内递送 microRNA 抑制肽核酸(PNA)的 PSNP 复合材料。虽然共聚物中 B 的摩尔百分比为 50(50B)时最有利于游离聚合物形式的早期内涵体逃逸,但当它形成 50B 聚合物涂覆 PSNP 复合材料(50BC)时,其 pH 开关被抑制。我们证明,基于具有最高内涵体破坏潜力和 miR-122 抑制活性,较低的 B 摩尔百分比(30BC)是 PSNP/PEG-DB 纳米复合材料的理想 PEG-DB 组成。在 1mM PNA 剂量下,与 40BC(=0.0095)、50BC(<0.0001)或用商业转染试剂 Fugene 6 递送的抗 miR-122 寡核苷酸相比,30BC 更能有效抑制 miR-122。使用活细胞半乳糖凝集素 8 基于内涵体破坏的报告器,在处理后 2 小时内,30BC 比 40BC 和 50BC 具有更大的内涵体逃逸,这表明快速内涵体逃逸与更高的细胞内生物活性相关。这项研究提供了关于聚合物结构依赖性对稳定性、内涵体逃逸和载药细胞内生物利用度的新见解,为具有内涵体溶酶体的 PSNP 聚合物涂层提供了新的见解。

相似文献

1
Tuning Composition of Polymer and Porous Silicon Composite Nanoparticles for Early Endosome Escape of Anti-microRNA Peptide Nucleic Acids.调整聚合物和多孔硅复合纳米粒子的组成以实现抗 microRNA 肽核酸的早期内体逃逸。
ACS Appl Mater Interfaces. 2020 Sep 2;12(35):39602-39611. doi: 10.1021/acsami.0c05827. Epub 2020 Aug 21.
2
Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids as Anti-MicroRNA Therapies.多孔硅和聚合物纳米复合材料用于递送肽核酸作为抗 microRNA 治疗药物。
Adv Mater. 2016 Sep;28(36):7984-7992. doi: 10.1002/adma.201601646. Epub 2016 Jul 6.
3
Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo.聚乙二醇化 siRNA 超分子复合物中阳离子和疏水性含量的平衡可增强内涵体逃逸、稳定性、血液循环时间和体内生物活性。
ACS Nano. 2013 Oct 22;7(10):8870-80. doi: 10.1021/nn403325f. Epub 2013 Sep 23.
4
Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.通过与 RAFT 合成的内溶酶体聚合物缀合,将促凋亡肽递送至细胞内。
Mol Pharm. 2010 Apr 5;7(2):468-76. doi: 10.1021/mp9002267.
5
Tuning the Loading and Release Properties of MicroRNA-Silencing Porous Silicon Nanoparticles by Using Chemically Diverse Peptide Nucleic Acid Payloads.通过使用化学多样化的肽核酸有效载物来调节 miRNA 沉默多孔硅纳米颗粒的加载和释放特性。
ACS Biomater Sci Eng. 2022 Oct 10;8(10):4123-4131. doi: 10.1021/acsbiomaterials.1c00431. Epub 2021 Sep 1.
6
Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencing.三元 siRNA 纳米粒的核心聚合物优化可提高体内安全性、药代动力学和肿瘤基因沉默。
Biomaterials. 2023 Jun;297:122098. doi: 10.1016/j.biomaterials.2023.122098. Epub 2023 Mar 28.
7
Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering.通过两性离子双层聚合物表面工程增强多孔硅纳米粒子的细胞内转运和内涵体逃逸。
Biomaterials. 2014 Aug;35(26):7488-500. doi: 10.1016/j.biomaterials.2014.05.020. Epub 2014 Jun 3.
8
Modifying Cell Membranes with Anionic Polymer Amphiphiles Potentiates Intracellular Delivery of Cationic Peptides.阴离子聚合物两亲物修饰细胞膜可增强阳离子肽的细胞内递送。
ACS Appl Mater Interfaces. 2020 Nov 11;12(45):50222-50235. doi: 10.1021/acsami.0c13304. Epub 2020 Oct 30.
9
pH-responsive three-layered PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer as a targetable and endosome-disruptive nonviral gene vector.基于乳糖基化ABC三嵌段共聚物的pH响应性三层聚乙二醇化多聚体胶束,作为一种可靶向且能破坏内体的非病毒基因载体。
Bioconjug Chem. 2006 May-Jun;17(3):677-88. doi: 10.1021/bc050364m.
10
Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.Gal8 可视化内体破坏预测载体介导的生物药物细胞内生物利用度。
ACS Nano. 2019 Feb 26;13(2):1136-1152. doi: 10.1021/acsnano.8b05482. Epub 2019 Jan 18.

引用本文的文献

1
Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands.脑靶向药物递送 - 通过脑靶向配体将纳米囊泡递送到特定的脑细胞。
J Nanobiotechnology. 2024 May 17;22(1):260. doi: 10.1186/s12951-024-02511-7.
2
Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics.用于高效递送抗miRNA肽核酸(PNA)和miRNA模拟物的阳离子杯[4]芳烃载体
Pharmaceutics. 2023 Aug 10;15(8):2121. doi: 10.3390/pharmaceutics15082121.
3
Nonviral Delivery of CRISPR-Cas9 Using Protein-Agnostic, High-Loading Porous Silicon and Polymer Nanoparticles.使用蛋白非依赖型、高载量多孔硅和聚合物纳米颗粒的非病毒 CRISPR-Cas9 递送。
ACS Nano. 2023 Sep 12;17(17):16412-16431. doi: 10.1021/acsnano.2c12261. Epub 2023 Aug 15.
4
Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy.用于全身性癌症治疗的pH响应型药物递送系统的当前原理、挑战和新指标
Pharmaceutics. 2023 May 22;15(5):1566. doi: 10.3390/pharmaceutics15051566.
5
Inorganic/organic combination: Inorganic particles/polymer composites for tissue engineering applications.无机/有机结合:用于组织工程应用的无机颗粒/聚合物复合材料。
Bioact Mater. 2023 Jan 11;24:535-550. doi: 10.1016/j.bioactmat.2023.01.003. eCollection 2023 Jun.
6
Nanocarrier system: An emerging strategy for bioactive peptide delivery.纳米载体系统:一种用于生物活性肽递送的新兴策略。
Front Nutr. 2022 Dec 5;9:1050647. doi: 10.3389/fnut.2022.1050647. eCollection 2022.
7
Multifunctional Delivery Systems for Peptide Nucleic Acids.用于肽核酸的多功能递送系统。
Pharmaceuticals (Basel). 2020 Dec 25;14(1):14. doi: 10.3390/ph14010014.

本文引用的文献

1
Amino-acid functionalized porous silicon nanoparticles for the delivery of pDNA.用于递送质粒DNA的氨基酸功能化多孔硅纳米颗粒
RSC Adv. 2019 Oct 7;9(55):31895-31899. doi: 10.1039/c9ra05461h.
2
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticles.一种阴离子型、可逃避内涵体的聚合物,可增强阳离子肽、生物大分子和纳米颗粒的细胞内递送。
Nat Commun. 2019 Nov 1;10(1):5012. doi: 10.1038/s41467-019-12906-y.
3
Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy.肿瘤靶向、微 RNA 沉默多孔硅纳米粒子用于卵巢癌治疗。
ACS Appl Mater Interfaces. 2019 Jul 10;11(27):23926-23937. doi: 10.1021/acsami.9b07980. Epub 2019 Jun 28.
4
Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.Gal8 可视化内体破坏预测载体介导的生物药物细胞内生物利用度。
ACS Nano. 2019 Feb 26;13(2):1136-1152. doi: 10.1021/acsnano.8b05482. Epub 2019 Jan 18.
5
To degrade or not to degrade: mechanisms and significance of endocytic recycling.降解还是不降解:内吞体循环的机制和意义。
Nat Rev Mol Cell Biol. 2018 Nov;19(11):679-696. doi: 10.1038/s41580-018-0053-7.
6
Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.使用 PEI 封端的多孔硅纳米粒子在体外和体内递送 siRNA 以沉默 MRP1 并抑制脑胶质瘤的增殖。
J Nanobiotechnology. 2018 Apr 13;16(1):38. doi: 10.1186/s12951-018-0365-y.
7
Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy.为生物医学应用定制多孔硅:从药物输送到癌症免疫治疗。
Adv Mater. 2018 Jun;30(24):e1703740. doi: 10.1002/adma.201703740. Epub 2018 Mar 13.
8
Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.选择性 mTORC2 抑制剂治疗性阻断乳腺癌细胞生长和存活。
Cancer Res. 2018 Apr 1;78(7):1845-1858. doi: 10.1158/0008-5472.CAN-17-2388. Epub 2018 Jan 22.
9
Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem.进入与突破:细胞穿透肽与内体逃逸问题
Biomol Concepts. 2017 Sep 26;8(3-4):131-141. doi: 10.1515/bmc-2017-0023.
10
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.介孔二氧化硅纳米颗粒作为癌症治疗中的药物递送载体
Nanomaterials (Basel). 2017 Jul 22;7(7):189. doi: 10.3390/nano7070189.